CR

Corey Ritter

ARCH Venture Partners

Greater Chicago Area

Invests in

Stages:

  • Min Investment:

    $50,000.00
  • Max Investment:

    $150,000,000.00
  • Target Investment:

    $25,000,000.00

Work Experience

  • Principal

    2017

    ARCH creates and invests in companies commercializing disruptive new technology developed by leading scientific researchers. I focus on life science tools and therapeutic platforms. Also: biotechnology, diagnostics, medical devices, quantum computing, materials, semiconductors, nanotechnology, autonomous systems, additive manufacturing, robotics.

  • Board Member

    2021

  • Board Member

    2021

2019

  • Board Observer

    2019

    Business development for company creation; led Series A financing.

  • Board Observer

    2019

    Business development for company creation; led Series A financing.

2022

  • Board Observer

    2022

2018 - 2021

  • Board Observer

    2018 - 2021

    NASDAQ: MASS

2017 - 2017

  • George Schultz Innovation Fund Associate

    2017 - 2017

    The Innovation Fund invests in science-based startups emanating from U-Chicago and Argonne National Lab. I led seed investments in two pre-clinical therapeutics startups.

  • Business Development

    2017 - 2017

    Startup commercializing novel water de-ionization materials technology developed at Argonne National Lab for use in water cooling towers. We competed in Chicago-Booth's New Venture Challenge

2016 - 2017

  • Associate

    2016 - 2017

    Led screening and diligence for healthcare tech investments.